Identification of exon 19 and 21 mutations of EGFR gene in Chinese patients with esophageal squamous cell carcinoma

BACKGROUND: Although epidermal growth factor receptor (EGFR) inhibitor treatment showed modest response in several clinical trials in esophageal squamous cell carcinoma (ESCC) patients, it has been reported that the frequency of EGFR mutations varied largely. The aim of this study was to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yong, Chang, Dong, Liu, Mingliang, Lin, Changjin, Zhao, Baojian, Zhang, Xu, Gong, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Technical Innovations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853380/
https://www.ncbi.nlm.nih.gov/pubmed/24103528
http://dx.doi.org/10.1186/1477-7819-11-266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853380/
https://www.ncbi.nlm.nih.gov/pubmed/24103528
http://dx.doi.org/10.1186/1477-7819-11-266

Ejemplares similares